ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Bukwang Pharma subsidiary raises 3 billion won biospectrumasia
July 15, 2019Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A from Medici Investments.?Conterapa expects JM-010, which is underway in Europe, to accelerate its Phase 2 clinical trials.
Pharma Sources Insight January 2025
